[The value of radiotherapy after modified radical mastectomy. 10-year results of the Heidelberg study].
Modified radical mastectomy was performed in 142 female patients with operable carcinoma of the breast. One of the two prospectively randomised groups received postoperative radiotherapy with 6000 rad. Survival rates were equal for both groups. Follow-up radiotherapy had a beneficial influence on survival rate and rate of distant metastases in median tumour sites. In lateral tumour localization the course of disease was less favourable with radiotherapy than without. Local relapse rates were slightly, however not significantly, lower after irradiation. The decisive prognostic criterium is T- and N-stage at the time of diagnosis.
D002293:Adenocarcinoma, Scirrhous / Q000401:mortality; D001943:Breast Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000401:mortality; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008408:Mastectomy / Q000379:methods*; D009367:Neoplasm Staging
Der Wert der Strahlentherapie nach modifiziert radikaler Mastektomie. 10-Jahres-Ergebnisse der Heidelberger Studie.